Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Lost Civilizations
>
Allos Therapeutics
>
Wall Street Thinks Folotyn is a bust
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 3780627"]I interviewed with the company, went to their office outside of Denver back in 2009. I called the next day to tell them to withdraw my name from consideration.</p><p><br /></p><p>Got a bad feeling about the middle and upper management, too few had real oncology experience. That lack of experience has borne itself out, I know of no sales rep who likes it there, the management is too primary-care in their style and tactics</p><p><br /></p><p>Plus the middle management acknowledged that the upper management was probably looking to sell the company as quickly as possible after drug approval, a quick in and out by the investors. That did not pan out, which is more damning when you consider that all the big companies are looking to buy up smaller companies and/or drugs. None of them will buy Floppin Folotyn. </p><p><br /></p><p>Regarding the drug, decent data. Side effects high, but manageable. Competes against clinical trials of other drugs that have initially appeared to be just as efficacious, with significantly less side effects.</p><p><br /></p><p>PTCL seems to be in pockets around the States, not evenly dispersed. </p><p><br /></p><p>Many many factors involved why this company is a bad place to invest.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 3780627"]I interviewed with the company, went to their office outside of Denver back in 2009. I called the next day to tell them to withdraw my name from consideration. Got a bad feeling about the middle and upper management, too few had real oncology experience. That lack of experience has borne itself out, I know of no sales rep who likes it there, the management is too primary-care in their style and tactics Plus the middle management acknowledged that the upper management was probably looking to sell the company as quickly as possible after drug approval, a quick in and out by the investors. That did not pan out, which is more damning when you consider that all the big companies are looking to buy up smaller companies and/or drugs. None of them will buy Floppin Folotyn. Regarding the drug, decent data. Side effects high, but manageable. Competes against clinical trials of other drugs that have initially appeared to be just as efficacious, with significantly less side effects. PTCL seems to be in pockets around the States, not evenly dispersed. Many many factors involved why this company is a bad place to invest.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Lost Civilizations
>
Allos Therapeutics
>
Wall Street Thinks Folotyn is a bust
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Lost Civilizations
>
Allos Therapeutics
>
Wall Street Thinks Folotyn is a bust
>